Primary anogenital squamous cell carcinoma (SCC), a locally aggressive malignancy, necessitated careful surgical margin consideration, and its impact on QoL due to tissue removal and dysfunction ...

18% margin. Net Result: SEK36 million for the quarter. Closing Cash: SEK968 million. Surgical Science Sweden AB (SUSRF) achieved record sales of SEK252 million in Q4 2024, marking a strong end to ...

As production is disrupted and profit margins decrease due to late deliveries and widespread inflation, the urgency for creative and cost-effective solutions has never been greater. Current conditions ...

Looking ahead, Surgical Science has set ambitious financial targets for 2026, aiming for SEK 1.5 billion in revenue and a 40% adjusted EBIT margin. The company remains optimistic about the ...

Association between baseline and changes in hemoglobin levels and treatment response and prognosis in metastatic renal cell carcinoma: A Mexican retrospective study.

STAAR Surgical Company (NASDAQ ... We continue to outpace the US refractive market by a large margin as we refine and execute against our Highway 93 and Fast Lane commercial strategies in the ...

Net Margin: Staar Surgical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.27%, the company showcases strong ...